Shire bid for Baxalta highlights orphan drug's appeal
Faced with expiring patents and growing competition from generics, pharmaceutical companies increasingly view orphan drugs as a key pathway to growth.
Aug 6, 2015
0
4
Faced with expiring patents and growing competition from generics, pharmaceutical companies increasingly view orphan drugs as a key pathway to growth.
Aug 6, 2015
0
4
While the use of antiangiogenesis drugs that block the growth of new blood vessels can improve the treatment of some cancers, clinical trials of their ability to prevent the development of new metastases have failed. Now ...
Jun 25, 2015
0
11
A doctors group is proposing a formula to help cancer patients decide if a drug is worth it—what it will cost them and how much good it is likely to do.
Jun 22, 2015
0
9
Although radiation treatments have become much more refined in recent years, it remains a challenge to both sufficiently dose the tumor while sparing the surrounding tissue. A new anti-cancer drug, already in clinical development, ...
Nov 14, 2014
0
0
Researchers have developed a new approach to characterizing and monitoring changes in cellular structure. The new type of single-cell-based assay, developed by researchers at Roswell Park Cancer Institute (RPCI) and the University ...
Oct 20, 2014
0
0
Two studies published in the October 2014 issue of Health Affairs by a University of Chicago health economist examine spending on oral anti-cancer drugs as well as a federal program designed to help the poor, which researchers ...
Oct 6, 2014
0
0
Combining a standard chemotherapy drug with a second drug that stops cells from dividing improves both the survival and response rates for those with advanced cervical cancer, a new study by UT Southwestern Medical Center ...
Sep 16, 2014
0
0
Findings of a trial of a drug aimed at treating advanced oesophageal - or gullet - cancer could lead to a new treatment approach for a sub-group of patients with this kind of cancer.
Aug 22, 2014
0
0
For patients with KRAS wild-type untreated colorectal cancer, adding cetuximab or bevacizumab to combination chemotherapy offers equivalent survival, researchers said at the ESMO 16th World Congress on Gastrointestinal Cancer ...
Jun 28, 2014
0
0
A multi-center phase I study using an investigational drug for advanced bladder cancer patients who did not respond to other treatments has shown promising results in patients with certain tumor types, researchers report. ...
May 31, 2014
0
0